NASDAQ:RDNT - RadNet Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $33.00
  • Forecasted Upside: -4.90 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.2 (3.58%)

This chart shows the closing price for RDNT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RadNet Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RDNT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RDNT

Analyst Price Target is $33.00
▼ -4.90% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for RadNet in the last 3 months. The average price target is $33.00, with a high forecast of $40.00 and a low forecast of $26.00. The average price target represents a -4.90% upside from the last price of $34.70.

This chart shows the closing price for RDNT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in RadNet. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/14/2021SidotiBoost Price TargetBuy$30.00 ➝ $40.00Low
3/9/2021Raymond JamesBoost Price TargetOutperform$22.00 ➝ $26.00High
8/11/2020Raymond JamesBoost Price TargetOutperform$18.50 ➝ $22.00Medium
5/26/2020SidotiBoost Price TargetBuy$17.00 ➝ $23.00High
2/21/2020SidotiBoost Price TargetBuy$23.00 ➝ $28.00Medium
12/2/2019SidotiBoost Price TargetBuy$20.00 ➝ $23.00High
3/15/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$16.00 ➝ $17.50High
3/14/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$15.00Low
3/14/2018FIXInitiated CoverageStrong-Buy$15.00High
3/8/2018Jefferies Financial GroupSet Price TargetBuy$14.00High
8/22/2017Jefferies Financial GroupUpgradeHold ➝ Buy$7.00 ➝ $12.00High
3/16/2017Jefferies Financial GroupSet Price TargetHold$7.00High
11/10/2016Jefferies Financial GroupReiterated RatingHold$7.00N/A
11/9/2016Craig HallumDowngradeBuy ➝ HoldN/A
9/3/2016B. RileyReiterated RatingBuy$9.00N/A
8/29/2016B. RileyReiterated RatingBuy$9.00N/A
8/14/2016B. RileyReiterated RatingBuy$9.00N/A
8/9/2016B. RileyReiterated RatingBuy$9.00N/A
8/5/2016Jefferies Financial GroupReiterated RatingHoldN/A
8/4/2016B. RileyReiterated RatingBuy$9.00N/A
(Data available from 7/25/2016 forward)
RadNet logo
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems. As of March 8, 2021, it owned and/or operated 331 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1985 and is headquartered in Los Angeles, California.
Read More

Today's Range

Now: $34.70
Low: $34.40
High: $35.75

50 Day Range

MA: $31.36
Low: $23.39
High: $36.00

52 Week Range

Now: $34.70
Low: $13.49
High: $36.64


275,363 shs

Average Volume

234,699 shs

Market Capitalization

$1.83 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of RadNet?

The following Wall Street sell-side analysts have issued research reports on RadNet in the last twelve months: Raymond James, Sidoti, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for RDNT.

What is the current price target for RadNet?

2 Wall Street analysts have set twelve-month price targets for RadNet in the last year. Their average twelve-month price target is $33.00, suggesting a possible downside of 4.9%. Sidoti has the highest price target set, predicting RDNT will reach $40.00 in the next twelve months. Raymond James has the lowest price target set, forecasting a price of $26.00 for RadNet in the next year.
View the latest price targets for RDNT.

What is the current consensus analyst rating for RadNet?

RadNet currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RDNT will outperform the market and that investors should add to their positions of RadNet.
View the latest ratings for RDNT.

What other companies compete with RadNet?

How do I contact RadNet's investor relations team?

RadNet's physical mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The medical research company's listed phone number is (310) 478-7808 and its investor relations email address is [email protected] The official website for RadNet is